This inventor holds 1 USPTO granted patent. Top assignee: Toyama Chemical Co., Ltd.. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987
Title: Hidetoshi Endo: Innovator in Dementia Therapeutics
Introduction
Hidetoshi Endo is a notable inventor based in Ichinomiya, Japan. He has made significant contributions to the field of neuropsychiatric treatments, particularly focusing on dementia. His innovative work has led to the development of therapeutic agents aimed at improving the quality of life for individuals suffering from dementia-related symptoms.
Latest Patents
Hidetoshi Endo holds a patent for a dementia-improving and therapeutic agent. This agent is designed to address neuropsychiatric symptoms associated with dementia. The active ingredient in this therapeutic agent is an acyloxyalkanoylcholine salt, which is represented by a specific general formula. This formula includes lower alkyl groups and a sulfonic acid residue, showcasing the complexity and innovation behind his invention. He has 1 patent to his name.
Career Highlights
Endo's career has been marked by his dedication to research and development in the pharmaceutical industry. He is currently associated with Toyama Chemical Co., Ltd., where he continues to work on innovative solutions for mental health challenges. His expertise in neuropsychiatric treatments has positioned him as a key figure in this specialized field.
Collaborations
Hidetoshi Endo collaborates with Fumio Kuzuya, contributing to the advancement of therapeutic agents for dementia. Their partnership exemplifies the importance of teamwork in the pursuit of innovative healthcare solutions.
Conclusion
Hidetoshi Endo's work in developing therapeutic agents for dementia highlights his commitment to improving mental health treatments. His innovative approach and collaboration with fellow researchers continue to pave the way for advancements in this critical area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile